logo
#

Latest news with #DayneWilliams

Quantum Health Signs Agreement to Acquire Embold Health
Quantum Health Signs Agreement to Acquire Embold Health

Associated Press

time6 days ago

  • Business
  • Associated Press

Quantum Health Signs Agreement to Acquire Embold Health

DUBLIN, Ohio & NASHVILLE, Tenn.--(BUSINESS WIRE)--Jun 4, 2025-- Quantum Health ('Quantum'), the creator of healthcare navigation, has signed a definitive agreement to acquire Embold Health ('Embold'), a leading physician-led healthcare technology company. The transaction is expected to close within the next 14 days, subject to customary closing conditions and regulatory approvals. This press release features multimedia. View the full release here: This strategic move deepens Quantum's investment in AI-powered personalization, significantly enhancing its Real-Time Intercept ® (RTI) and provider engagement capabilities to guide members to cost-effective, high-quality care while driving ROI for clients. Together, Quantum and Embold will offer an expanded portfolio of products to the market. 'By joining forces, we're not just adding technology — we're elevating the standard for healthcare navigation,' said Dayne Williams, CEO of Quantum. 'Our Healthcare Warriors ®, already known for their compassion and expertise, will be equipped with even more powerful tools to guide members to the best care. When you combine our high provider and member Net Promoter Scores ® (NPS) with Embold's AI, you get a complete, intelligent and human-centered navigation experience built to deliver ROI.' The acquisition builds on a strong existing partnership between the two organizations. By pairing Embold's proven provider quality analytics and conversational AI capabilities with Quantum's 26-year legacy of navigation expertise and unparalleled provider relationships, the combined entity is well-positioned to redefine the way consumers engage with healthcare. Embold will continue to operate as an independent entity, upholding its commitment to delivering exceptional service to its clients. With enhanced investment and resources from Quantum, Embold will accelerate the advancement of its product roadmap, further strengthening its ability to serve clients with innovative, data-driven solutions. 'This is about bringing together two companies with shared missions,' said Dr. Daniel Stein, CEO and Founder of Embold, who will now serve as President of Embold. 'Together, we remain focused on delivering the trusted insights our clients count on, with enhanced capabilities to help even more members access higher-quality care.' Integrating with Embold's proprietary physician-level analytics and AI-powered provider recommendation engine, Quantum will deliver the most complete navigation experience in the industry — one that balances trust, quality and action. The combined company will serve more than 8 million members nationwide, increasing the scale and scope of its products and capabilities. Raymond James & Associates, Inc. served as financial advisor, and Mayer Brown LLP served as legal counsel to Embold Health, while Kirkland & Ellis LLP served as legal counsel to Quantum. About Quantum Health Quantum Health is the industry-leading consumer healthcare navigation and care coordination company that delivers an unparalleled consumer experience to its members, as well as validated claims savings and high satisfaction rates for its self-insured employer and payer clients. Quantum Health's proprietary Real-Time Intercept® capability identifies opportunities for early intervention in a member's healthcare journey, resulting in better engagement, outcomes and cost efficiencies. Founded in 1999 and based in Dublin, Ohio, Quantum Health has earned numerous awards and honors, including being named among the Fastest-Growing Private Companies by Inc. 5000, a Great Place to Work by FORTUNE Magazine and Entrepreneur Magazine, and one of FORTUNE'S Best Workplaces in Healthcare. The Women Presidents' Organization has also ranked Quantum Health as one of the 50 Fastest-Growing Women-Owned/Led Companies for over 15 years. To learn more about the company, visit and connect with us on LinkedIn and X. About Embold Health Embold Health, a healthcare technology company, helps employers and health plans improve outcomes and lower costs by empowering members to make informed healthcare decisions. Evaluating 21 specialties and 68 sub-specialties, Embold's patented and peer-reviewed provider quality score methodology analyzes data from 230+ million individuals across the entire care journey at the individual physician performance level. Setting the standard for responsible AI in healthcare, Embold's conversational AI simplifies the care-seeking process. Paving the way for more efficient, personalized, and cost-effective care, Embold is transforming how care is sought out and delivered. To learn more, visit Disclaimer This announcement contains forward-looking statements, which are subject to risks and uncertainties. These statements include, but are not limited to, expectations regarding the completion and timing of the proposed acquisition. Actual results may differ materially due to various factors, including the satisfaction of closing conditions and other unforeseen developments. View source version on CONTACT: Media Contact Alison Travis Corporate Communications Manager [email protected] 220-465-9386 KEYWORD: TENNESSEE OHIO UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: TECHNOLOGY HEALTH TECHNOLOGY PROFESSIONAL SERVICES SOFTWARE PRACTICE MANAGEMENT GENERAL HEALTH DATA ANALYTICS HEALTH DATA MANAGEMENT ARTIFICIAL INTELLIGENCE SOURCE: Quantum Health Copyright Business Wire 2025. PUB: 06/04/2025 08:15 AM/DISC: 06/04/2025 08:15 AM

Quantum Health Signs Agreement to Acquire Embold Health
Quantum Health Signs Agreement to Acquire Embold Health

Business Wire

time6 days ago

  • Business
  • Business Wire

Quantum Health Signs Agreement to Acquire Embold Health

DUBLIN, Ohio & NASHVILLE, Tenn.--(BUSINESS WIRE)-- Quantum Health ('Quantum'), the creator of healthcare navigation, has signed a definitive agreement to acquire Embold Health ('Embold'), a leading physician-led healthcare technology company. The transaction is expected to close within the next 14 days, subject to customary closing conditions and regulatory approvals. 'By joining forces with Embold Health, we're not just adding technology — we're elevating the standard for healthcare navigation,' said Dayne Williams, CEO of Quantum Health. This strategic move deepens Quantum's investment in AI-powered personalization, significantly enhancing its Real-Time Intercept ® (RTI) and provider engagement capabilities to guide members to cost-effective, high-quality care while driving ROI for clients. Together, Quantum and Embold will offer an expanded portfolio of products to the market. 'By joining forces, we're not just adding technology — we're elevating the standard for healthcare navigation,' said Dayne Williams, CEO of Quantum. 'Our Healthcare Warriors ®, already known for their compassion and expertise, will be equipped with even more powerful tools to guide members to the best care. When you combine our high provider and member Net Promoter Scores ® (NPS) with Embold's AI, you get a complete, intelligent and human-centered navigation experience built to deliver ROI.' The acquisition builds on a strong existing partnership between the two organizations. By pairing Embold's proven provider quality analytics and conversational AI capabilities with Quantum's 26-year legacy of navigation expertise and unparalleled provider relationships, the combined entity is well-positioned to redefine the way consumers engage with healthcare. Embold will continue to operate as an independent entity, upholding its commitment to delivering exceptional service to its clients. With enhanced investment and resources from Quantum, Embold will accelerate the advancement of its product roadmap, further strengthening its ability to serve clients with innovative, data-driven solutions. 'This is about bringing together two companies with shared missions,' said Dr. Daniel Stein, CEO and Founder of Embold, who will now serve as President of Embold. 'Together, we remain focused on delivering the trusted insights our clients count on, with enhanced capabilities to help even more members access higher-quality care.' Integrating with Embold's proprietary physician-level analytics and AI-powered provider recommendation engine, Quantum will deliver the most complete navigation experience in the industry — one that balances trust, quality and action. The combined company will serve more than 8 million members nationwide, increasing the scale and scope of its products and capabilities. Raymond James & Associates, Inc. served as financial advisor, and Mayer Brown LLP served as legal counsel to Embold Health, while Kirkland & Ellis LLP served as legal counsel to Quantum. About Quantum Health Quantum Health is the industry-leading consumer healthcare navigation and care coordination company that delivers an unparalleled consumer experience to its members, as well as validated claims savings and high satisfaction rates for its self-insured employer and payer clients. Quantum Health's proprietary Real-Time Intercept® capability identifies opportunities for early intervention in a member's healthcare journey, resulting in better engagement, outcomes and cost efficiencies. Founded in 1999 and based in Dublin, Ohio, Quantum Health has earned numerous awards and honors, including being named among the Fastest-Growing Private Companies by Inc. 5000, a Great Place to Work by FORTUNE Magazine and Entrepreneur Magazine, and one of FORTUNE'S Best Workplaces in Healthcare. The Women Presidents' Organization has also ranked Quantum Health as one of the 50 Fastest-Growing Women-Owned/Led Companies for over 15 years. To learn more about the company, visit and connect with us on LinkedIn and X. About Embold Health Embold Health, a healthcare technology company, helps employers and health plans improve outcomes and lower costs by empowering members to make informed healthcare decisions. Evaluating 21 specialties and 68 sub-specialties, Embold's patented and peer-reviewed provider quality score methodology analyzes data from 230+ million individuals across the entire care journey at the individual physician performance level. Setting the standard for responsible AI in healthcare, Embold's conversational AI simplifies the care-seeking process. Paving the way for more efficient, personalized, and cost-effective care, Embold is transforming how care is sought out and delivered. To learn more, visit Disclaimer This announcement contains forward-looking statements, which are subject to risks and uncertainties. These statements include, but are not limited to, expectations regarding the completion and timing of the proposed acquisition. Actual results may differ materially due to various factors, including the satisfaction of closing conditions and other unforeseen developments.

Quantum Health Partners with Vida Health to Launch New GLP-1 Weight Management Solution as Part of Company's Premier Pharmacy Navigation Platform
Quantum Health Partners with Vida Health to Launch New GLP-1 Weight Management Solution as Part of Company's Premier Pharmacy Navigation Platform

Yahoo

time20-03-2025

  • Business
  • Yahoo

Quantum Health Partners with Vida Health to Launch New GLP-1 Weight Management Solution as Part of Company's Premier Pharmacy Navigation Platform

New solution leverages Quantum Health's clinical expertise, health coaching and holistic care coordination combined with Vida Health's evidence-based prescribing to optimize GLP-1 utilization, improve the sustainability of obesity treatment and related conditions, and deliver cost savings for employers. DUBLIN, Ohio & SAN FRANCISCO, March 20, 2025--(BUSINESS WIRE)--Quantum Health, the leader in healthcare navigation and care coordination, announced today it has expanded its Premier Pharmacy platform to offer self-insured employers a new GLP-1 solution, powered by Vida Health, optimizing prescribing patterns, clinical outcomes and member support for weight loss. Quantum Health's new solution focuses on managing drug utilization patterns to align treatment with need, supporting employers in ensuring the effective use of GLP-1s and other weight management therapies. Vida Health serves as the provider partner, ensuring members receive evidence-based, clinically appropriate prescriptions. The program begins with holistic behavior change and less intensive anti-obesity medications (AOMs), with only 14% of members starting on a GLP-1 compared with the average 40%-50% in unmanaged care settings. An August 2024 employer survey conducted by the Business Group on Health found that 79% of employers have seen an increase by covered members' interest in weight management medications, including GLP-1s, as more employees qualify for coverage. While 96% of employers cover GLP-1s for diabetes, 67% are expanding coverage to include weight management, and often struggle to manage costs and appropriate use. With this rising demand and broader eligibility, 96% of employers worry about the long-term cost implications, highlighting ongoing challenges in managing overall drug expenses. "The launch of our GLP-1 weight management solution is the latest example of our commitment to helping our employer clients with improved utilization of these drugs through better management of medication costs while ensuring members receive high-value, appropriate care," said Dayne Williams, CEO of Quantum Health. "GLP-1s and specialty drugs are a major and growing cost driver for all employers, who are seeing significant increases in employee demand for expanded GLP-1 coverage. Our comprehensive navigation platform uniquely positions us to manage employers' medical and pharmacy spend, delivering seamless support to meet members' needs and align outcomes with employer health plan designs." With obesity now recognized as a complex chronic disease by the Journal of the American Medical Association (JAMA), there is growing consensus that it requires comprehensive treatment rather than being viewed solely as a lifestyle condition. Affecting more than 42% of adults in the U.S., these obesity levels mean employers face growing pressure to address the rising demand for effective weight management treatments in their health plans. The MedCity News and Quantum Health's 2024 Benefit Consultant Sentiment Index (The Index) concurs, as it revealed that nearly two-thirds of health benefit consultants see a rise in demand for guidance on specialty drug and GLP-1 cost management. But according to a 2024 Kaiser Family Foundation survey, only one in four employers currently cover GLP-1 medications for weight loss, even as these treatments gain popularity. To help employers balance pharmacy cost management with high-quality health benefits under their medical and pharmacy benefits, Quantum Health launched its Premier Pharmacy platform in 2024, leveraging its clinical expertise to guide members toward effective, high-value care. The company serves over 500 self-insured employer clients and over 3 million members. Its established specialty pharmacy capability includes utilization management and a site-of-care program combined with its digital experience, proprietary Real-Time Intercept® capability, and an in-house Pharmacy Services team comprised of doctors, pharmacists and analysts to intercept members earlier in their care journeys to offer high-value, clinically appropriate medication alternatives. "We are honored to work with Quantum Health to address the growing GLP-1 spending challenge for employers," said Joe Murad, CEO at Vida Health. "Unlike models that rely on costly medications, our collaborative weight management solution delivers highly personalized, evidence-based clinical interventions that enhance outcomes, improve the member experience and align seamlessly with employers' goals." Core Elements of Quantum Health's New GLP-1 Weight Management Solution powered by Vida: Navigating member commitment: Quantum Health serves as the single point of contact providing benefits education and comprehensive clinical assessments to evaluate a member's readiness for change. Provider collaboration: Precertification of Vida Health as a responsible prescriber streamlines the process and ensures only evidence-based and cost-effective prescriptions are provided. Sustainable lifestyle changes: Members adopt and sustain healthier habits while the solution ensures therapeutic graduation to more holistic lifestyle practices. The solution will be available to early adopter employers in 2025, with plans to continue to expand Premier Pharmacy to address additional high-cost, high-priority pharmacy needs for employers. Learn more about Quantum Health's approach to pharmacy and its new GLP-1 Weight Management Solution powered by Vida Health: About Quantum HealthQuantum Health is the industry-leading consumer healthcare navigation and care coordination company that delivers an unparalleled consumer experience to its members, as well as validated claims savings and high satisfaction rates for its self-insured employer and payer clients. Quantum Health's proprietary Real-Time Intercept® capability identifies opportunities for early intervention in a member's healthcare journey, resulting in better engagement, outcomes and cost efficiencies. Founded in 1999 and based in Dublin, Ohio, Quantum Health has earned numerous awards and honors, including being named among the Fastest-Growing Private Companies by Inc. 5000, a Great Place to Work by FORTUNE Magazine and Entrepreneur Magazine, and one of FORTUNE'S Best Workplaces in Healthcare. The Women Presidents' Organization has also ranked Quantum Health as one of the 50 Fastest-Growing Women-Owned/Led Companies for over 15 years. To learn more about the company, visit and connect with us on LinkedIn and X. About Vida HealthVida Health is a virtual, personalized obesity care provider that helps patients manage obesity and related conditions like diabetes, high blood pressure, anxiety, and depression with evidence-based treatment. Vida's team of obesity medicine-certified physicians, registered dietitians, expert coaches, and licensed therapists take a whole-person approach leading to clinically meaningful body weight loss in one year. Practicing responsible prescribing, Vida supports patients, employers, and health plans by prioritizing proven behavior change and lifestyle interventions before introducing medications, ensuring that only those who need anti-obesity medications receive them — helping to control costs. Employers and health plans avoid prescription costs up to $475 per member per month for those with obesity. Vida serves members in all 50 states and Washington D.C., offers services in both English and Spanish, and operates on a value-based pricing model, putting outcomes at the center of care. To learn more, visit View source version on Contacts Quantum Health Media Contact: Susan SimkinsQuantum Health, Corporate 800-257-2038 x13494 Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store